Kering


Wait and see

01/09/25 -"Despite a better than feared operating profit in the first half and ongoing opex reduction, the group now expects the EBIT margin in H2 25 to decline further vs H2 24. This contrasts with ..."

Pages
64
Language
English
Published on
01/09/25
You may also be interested by these reports :
01/09/25
Despite a better than feared operating profit in the first half and ongoing opex reduction, the group now expects the EBIT margin in H2 25 to decline ...

01/09/25
The change of the target price reflects updated EPS estimates, DCF and peer-based valuations. Year-to-date, the share price has decreased by -38%, ...

14/08/25
More weakish 2Q25 results – FY25E outlook confirmed

11/08/25
Knaus reported mixed H1 results due to a strategic realignment, affected by a temporary production stoppage to support dealer destocking and ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO